(Note: Apnimed upsized its IPO at pricing to 12 million shares – up from 10 million shares in the prospectus – and priced the IPO at $16.00 – the top of its range – to raise $192 million on Thursday night, July 30, 2026. Background: Apnimed disclosed the terms for its IPO on July 27, 2026, in an S-1/A filing: 10 million shares at a price range of $14.00 to $16.00 to raise $150 million, if priced at the mid-point of its range. Background: Apnimed filed its S-1 on July 10, 2026, without disclosing the terms. Estimated proceeds were $100 million, a placeholder figure.)

Industry
Pharmaceuticals

CEO	CFO
-

Employees	Founded
65	2017

Contacts

Address: 39 John F. Kennedy Street, 4th Floor Cambridge, Ma 02138

Telephone: (617) 500-8880

Web page: http://www.apnimed.com/

IPO information

First Trade Date	7/31/2026
Status	Priced
Exchange	NASDAQ
Lockup Period Expiration	.Pro
Quiet Period Expiration	.Pro
Old Price Range	-

Share prices ($)

Shares & Volumes

Shares Initial (MM)	12
Shares Revised (MM)	12
Expected offer amount (MM)	$192
Realized offer amount(MM)	$192

Financial Data (last reporting year)

Market Cap (MM)	$640.0
Revenues (MM)	$120.15
Net Income (Loss) (MM)	$-31.83

Voting

What do you think will happen with the APMD share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes:

The lead left underwriter: BofA Securities

IPOs led by the firm	.Pro
Profitability of conducted IPOs ?	.Pro
1st day change ?	.Pro
Change for the first 3 months ?	.Pro

Underwriters
BofA Securities/Evercore ISI/Cantor/LifeSci Capital
CO-Managers

Tweets about $APMD

Tweets
Tweets volume

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats

Interest over time
Interest by region

Apnimed (APMD)

Buy Bitcoin

Free full financial analysis

IPO Pro-version